Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
25.96
-0.01 (-0.04%)
At close: Jul 25, 2025, 4:00 PM
25.90
-0.06 (-0.23%)
After-hours: Jul 25, 2025, 7:36 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.54 billion as of July 25, 2025. Its market cap has decreased by -28.90% in one year.
Market Cap
1.54B
Enterprise Value
548.20M
1-Year Change
-28.90%
Ranking
Category
Stock Price
$25.96
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.54B, an increase of 150.21%. That is a compound annual growth rate of 24.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 1.54B | -50.21% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |